CID 41841

Satranidazole

Structural Information

Molecular Formula
C8H11N5O5S
SMILES
CN1C(=CN=C1N2CCN(C2=O)S(=O)(=O)C)[N+](=O)[O-]
InChI
InChI=1S/C8H11N5O5S/c1-10-6(13(15)16)5-9-7(10)11-3-4-12(8(11)14)19(2,17)18/h5H,3-4H2,1-2H3
InChIKey
FNSHYEAUAUHIMB-UHFFFAOYSA-N
Compound name
1-(1-methyl-5-nitroimidazol-2-yl)-3-methylsulfonylimidazolidin-2-one
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

25
References

174
Patents

289.0481 Da
Monoisotopic Mass

-0.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 290.05538 159.4
[M+Na]+ 312.03732 168.2
[M+NH4]+ 307.08192 163.1
[M+K]+ 328.01126 170.9
[M-H]- 288.04082 158.1
[M+Na-2H]- 310.02277 160.9
[M]+ 289.04755 160.0
[M]- 289.04865 160.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe